vs

Side-by-side financial comparison of Taysha Gene Therapies, Inc. (TSHA) and Where Food Comes From, Inc. (WFCF). Click either name above to swap in a different company.

Where Food Comes From, Inc. is the larger business by last-quarter revenue ($6.0M vs $5.5M, roughly 1.1× Taysha Gene Therapies, Inc.). Where Food Comes From, Inc. runs the higher net margin — -3.4% vs -507.8%, a 504.4% gap on every dollar of revenue. On growth, Taysha Gene Therapies, Inc. posted the faster year-over-year revenue change (171.3% vs -9.3%). Over the past eight quarters, Taysha Gene Therapies, Inc.'s revenue compounded faster (26.8% CAGR vs 4.0%).

Taysha Gene Therapies, Inc. is a clinical-stage biotechnology company specializing in developing adeno-associated virus (AAV)-based gene therapies for rare monogenic central nervous system disorders with high unmet medical needs. Its core pipeline targets serious life-threatening neurological conditions, with primary operations and market focus across North America and European regions.

Where Food Comes From, Inc. is a leading provider of food traceability, verification, and certification solutions for the agricultural and food production industries. Its services support producers, processors, and retailers across North America to validate food origin, sustainability practices, animal welfare standards, and product authenticity for end consumers.

TSHA vs WFCF — Head-to-Head

Bigger by revenue
WFCF
WFCF
1.1× larger
WFCF
$6.0M
$5.5M
TSHA
Growing faster (revenue YoY)
TSHA
TSHA
+180.6% gap
TSHA
171.3%
-9.3%
WFCF
Higher net margin
WFCF
WFCF
504.4% more per $
WFCF
-3.4%
-507.8%
TSHA
Faster 2-yr revenue CAGR
TSHA
TSHA
Annualised
TSHA
26.8%
4.0%
WFCF

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
TSHA
TSHA
WFCF
WFCF
Revenue
$5.5M
$6.0M
Net Profit
$-27.9M
$-203.0K
Gross Margin
35.9%
Operating Margin
-516.0%
-1.0%
Net Margin
-507.8%
-3.4%
Revenue YoY
171.3%
-9.3%
Net Profit YoY
-48.3%
-121.1%
EPS (diluted)
$-0.08
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
TSHA
TSHA
WFCF
WFCF
Q4 25
$5.5M
$6.0M
Q3 25
$0
$7.0M
Q2 25
$2.0M
$6.6M
Q1 25
$2.3M
$5.3M
Q4 24
$2.0M
$6.7M
Q3 24
$1.8M
$7.1M
Q2 24
$1.1M
$6.4M
Q1 24
$3.4M
$5.6M
Net Profit
TSHA
TSHA
WFCF
WFCF
Q4 25
$-27.9M
$-203.0K
Q3 25
$-32.7M
$1.1M
Q2 25
$-26.9M
$562.0K
Q1 25
$-21.5M
$31.0K
Q4 24
$-18.8M
$961.0K
Q3 24
$-25.5M
$492.0K
Q2 24
$-20.9M
$489.0K
Q1 24
$-24.1M
$178.0K
Gross Margin
TSHA
TSHA
WFCF
WFCF
Q4 25
35.9%
Q3 25
38.3%
Q2 25
37.5%
Q1 25
41.6%
Q4 24
42.0%
Q3 24
39.0%
Q2 24
41.6%
Q1 24
41.7%
Operating Margin
TSHA
TSHA
WFCF
WFCF
Q4 25
-516.0%
-1.0%
Q3 25
8.2%
Q2 25
-1347.1%
8.4%
Q1 25
-930.5%
2.7%
Q4 24
-985.8%
11.3%
Q3 24
-1448.4%
8.6%
Q2 24
-1915.4%
9.1%
Q1 24
-713.3%
4.7%
Net Margin
TSHA
TSHA
WFCF
WFCF
Q4 25
-507.8%
-3.4%
Q3 25
16.3%
Q2 25
-1353.6%
8.6%
Q1 25
-935.2%
0.6%
Q4 24
-929.0%
14.4%
Q3 24
-1427.5%
6.9%
Q2 24
-1882.0%
7.6%
Q1 24
-705.4%
3.2%
EPS (diluted)
TSHA
TSHA
WFCF
WFCF
Q4 25
$-0.08
$-0.04
Q3 25
$-0.09
$0.22
Q2 25
$-0.09
$0.11
Q1 25
$-0.08
$0.01
Q4 24
$-0.07
$0.19
Q3 24
$-0.10
$0.09
Q2 24
$-0.09
$0.09
Q1 24
$-0.10
$0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
TSHA
TSHA
WFCF
WFCF
Cash + ST InvestmentsLiquidity on hand
$319.8M
$3.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$246.9M
$9.3M
Total Assets
$343.3M
$12.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
TSHA
TSHA
WFCF
WFCF
Q4 25
$319.8M
$3.2M
Q3 25
$297.3M
$4.8M
Q2 25
$312.8M
$3.2M
Q1 25
$116.6M
$2.2M
Q4 24
$139.0M
$2.0M
Q3 24
$157.7M
$2.8M
Q2 24
$172.7M
$2.6M
Q1 24
$124.0M
$1.9M
Stockholders' Equity
TSHA
TSHA
WFCF
WFCF
Q4 25
$246.9M
$9.3M
Q3 25
$219.0M
$10.3M
Q2 25
$248.7M
$10.0M
Q1 25
$55.1M
$9.6M
Q4 24
$71.5M
$9.9M
Q3 24
$88.8M
$9.5M
Q2 24
$108.9M
$9.7M
Q1 24
$53.8M
$9.6M
Total Assets
TSHA
TSHA
WFCF
WFCF
Q4 25
$343.3M
$12.9M
Q3 25
$316.6M
$16.9M
Q2 25
$333.3M
$16.6M
Q1 25
$138.4M
$15.2M
Q4 24
$160.4M
$15.3M
Q3 24
$180.2M
$16.9M
Q2 24
$200.4M
$16.8M
Q1 24
$153.0M
$15.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
TSHA
TSHA
WFCF
WFCF
Operating Cash FlowLast quarter
$-26.7M
$-707.0K
Free Cash FlowOCF − Capex
$-741.0K
FCF MarginFCF / Revenue
-12.3%
Capex IntensityCapex / Revenue
0.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$1.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
TSHA
TSHA
WFCF
WFCF
Q4 25
$-26.7M
$-707.0K
Q3 25
$-24.2M
$501.0K
Q2 25
$-20.2M
$1.2M
Q1 25
$-22.0M
$632.0K
Q4 24
$-18.3M
$-50.0K
Q3 24
$-21.6M
$912.0K
Q2 24
$-21.5M
$1.2M
Q1 24
$-19.8M
$700.0K
Free Cash Flow
TSHA
TSHA
WFCF
WFCF
Q4 25
$-741.0K
Q3 25
$-24.3M
$443.0K
Q2 25
$1.1M
Q1 25
$603.0K
Q4 24
$-18.3M
$-79.0K
Q3 24
$-21.6M
$873.0K
Q2 24
$-21.7M
$1.1M
Q1 24
$-19.9M
$676.0K
FCF Margin
TSHA
TSHA
WFCF
WFCF
Q4 25
-12.3%
Q3 25
6.3%
Q2 25
17.5%
Q1 25
11.4%
Q4 24
-905.5%
-1.2%
Q3 24
-1210.9%
12.3%
Q2 24
-1951.9%
17.2%
Q1 24
-584.5%
12.1%
Capex Intensity
TSHA
TSHA
WFCF
WFCF
Q4 25
0.6%
Q3 25
0.8%
Q2 25
0.5%
Q1 25
0.5%
Q4 24
0.1%
0.4%
Q3 24
2.0%
0.5%
Q2 24
18.1%
1.0%
Q1 24
4.1%
0.4%
Cash Conversion
TSHA
TSHA
WFCF
WFCF
Q4 25
Q3 25
0.44×
Q2 25
2.10×
Q1 25
20.39×
Q4 24
-0.05×
Q3 24
1.85×
Q2 24
2.39×
Q1 24
3.93×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

TSHA
TSHA

Segment breakdown not available.

WFCF
WFCF

Verification And Certification Service Revenue$5.0M83%
Other$1.0M17%

Related Comparisons